Rahman Z - Search Results

1

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.

Ueno NT, Rondón G, Mirza NQ, Geisler DK, Anderlini P, Giralt SA, Andersson BS, Claxton DF, Gajewski JL, Khouri IF, Körbling M, Mehra RC, Przepiorka D, Rahman Z, Samuels BI, van Besien K, Hortobagyi GN, Champlin RE. Ueno NT, et al. Among authors: rahman z. J Clin Oncol. 1998 Mar;16(3):986-93. doi: 10.1200/JCO.1998.16.3.986. J Clin Oncol. 1998. PMID: 9508181

2

Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection.

Montemurro F, Rondón G, Munsell M, Smith TL, Donato ML, Gajewski JL, Rahman ZU, Buzdar AU, Champlin RE, Ueno NT. Montemurro F, et al. Biol Blood Marrow Transplant. 2003 May;9(5):330-40. doi: 10.1016/s1083-8791(03)00088-0. Biol Blood Marrow Transplant. 2003. PMID: 12766883 Free article.

3

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.

Rahman ZU, Frye DK, Buzdar AU, Smith TL, Asmar L, Champlin RE, Hortobagyi GN. Rahman ZU, et al. J Clin Oncol. 1997 Oct;15(10):3171-7. doi: 10.1200/JCO.1997.15.10.3171. J Clin Oncol. 1997. PMID: 9336352

4

High-dose chemotherapy with autologous stem cell support in patients with breast cancer.

Rahman ZU, Hortobagyi GN, Buzdar AU, Champlin R. Rahman ZU, et al. Cancer Treat Rev. 1998 Aug;24(4):249-63. doi: 10.1016/s0305-7372(98)90060-3. Cancer Treat Rev. 1998. PMID: 9805506 Review. No abstract available.

5

Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.

Rahman Z, Champlin R, Rondon G, Frye D, Valero V, Mehra R, Hortobagyi G. Rahman Z, et al. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-77-S17-80. Semin Oncol. 1997. PMID: 9374100 Clinical Trial.

6

Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature.

Diaz-Canton EA, Valero V, Rahman Z, Rodriguez-Monge E, Frye D, Smith T, Buzdar AU, Hortobagyi GN. Diaz-Canton EA, et al. Among authors: rahman z. Ann Oncol. 1998 Apr;9(4):413-8. doi: 10.1023/a:1008205522875. Ann Oncol. 1998. PMID: 9636832 Free article.

7

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.

Valero V, Jones SE, Von Hoff DD, Booser DJ, Mennel RG, Ravdin PM, Holmes FA, Rahman Z, Schottstaedt MW, Erban JK, Esparza-Guerra L, Earhart RH, Hortobagyi GN, Burris HA 3rd. Valero V, et al. Among authors: rahman z. J Clin Oncol. 1998 Oct;16(10):3362-8. doi: 10.1200/JCO.1998.16.10.3362. J Clin Oncol. 1998. PMID: 9779713 Clinical Trial.

8

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.

Rahman Z, Kavanagh J, Champlin R, Giles R, Hanania E, Fu S, Zu Z, Mehra R, Holmes F, Kudelka A, Claxton D, Verschraegen C, Gajewski J, Andreeff M, Heimfeld S, Berenson R, Ellerson D, Calvert L, Mechetner E, Holzmayer T, Dayne A, Hamer J, Bachier C, Ostrove J, Deisseroth A, et al. Rahman Z, et al. Clin Cancer Res. 1998 Nov;4(11):2717-21. Clin Cancer Res. 1998. PMID: 9829734 Clinical Trial.

9

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.

Rivera E, Valero V, Syrewicz L, Rahman Z, Esteva FJ, Theriault RL, Rosales MM, Booser D, Murray JL, Bast RC Jr, Hortobagyi GN. Rivera E, et al. Among authors: rahman z. J Clin Oncol. 2001 Mar 15;19(6):1716-22. doi: 10.1200/JCO.2001.19.6.1716. J Clin Oncol. 2001. PMID: 11251001 Clinical Trial.

10

A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.

Giordano SH, Booser DJ, Murray JL, Ibrahim NK, Rahman ZU, Valero V, Theriault RL, Rosales MF, Rivera E, Frye D, Ewer M, Ordonez NG, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Clin Cancer Res. 2002 Nov;8(11):3360-8. Clin Cancer Res. 2002. PMID: 12429622 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

693 results

Search Page